Table II.
Body temperature and laboratory markers in patients with skin or soft tissue infection (SSTI) on the face
| SSTI Median (Q25–Q75) | HZ Median (Q25–Q75) | p-valuea | HZ with secondary infection Median (Q25–Q75) | p-valueb | |
|---|---|---|---|---|---|
| Body temperature (°C) | 37.4 (36.75–37.95, n = 37) | 36.8 (36.5–37.2, n = 69) | < 0.05 | 36.6 (36.3–37.3, n = 19) | 0.618 |
| C-reactive protein (< 0.5 mg/dl) | 4.80 (2.25–9.35, n = 40) | 0.50 (0–1.43, n = 75) | < 0.05 | 1.50 (0.5–4.8, n = 23) | < 0.05 |
| Leukocytes (3.91–10.9 × 109/l) | 839 (7.09–11.95, n = 40) | 668 (5.48–7.99, n = 75) | < 0.05 | 6.49 (4.99–9.92, n = 23) | 0825 |
| Erythrocytes (4.44–5.61 × 109/l) | 445 (3.9–4.83, n = 40) | 464 (4.29–4.94, n = 75) | 0.06 | 4.60 (4.26–5.01, n = 23) | 0.993 |
| Blood platelets (166–308 × 109/l) | 216 (184–249, n = 40) | 210 (181–255, n = 75) | 0.915 | 208 (189–231, n = 23) | 0.849 |
| Neutrophils (1.8–6.98 × 109/l) | 5.68 (4.31–8.28, n = 34) | 4.12 (3.36–5.71, n = 61) | < 0.05 | 3.73 (3.0–6.67, n = 15) | 0.766 |
| Lymphocytes (1.26–3.35 × 109/l) | 1.31 (1.10–2–20, n = 34) | 1.40 (0.90–1.71, n = 61) | 0.245 | 1.22 (0.74–2.15, n = 14) | 0.967 |
| Monocytes (0.29–0.96 × 109/l) | 0.73 (0.56–0.92, n = 34) | 0.74 (0.60–0.86, n = 61) | 0.718 | 0.71 (0.45–0.94, n = 14) | 0.822 |
| Eosinophils (0.03–0.59 × 109/l) | 0.07 (0.03–0.14, n = 34) | 0.10 (0.03–0.15, n = 61) | 0.797 | 0.07 (0.03–0.12, n = 15) | 0.451 |
| Basophil (0.01–0.07 × 109/l) | 0.03 (0.02–0.04, n = 34) | 0.04 (0.02–0.06, n = 61) | < 0.05 | 0.03 (0.03–0.53, n = 14) | 0.390 |
| Immature granulocytes (≤ 0.06 × 109/l) | 0.03 (0.2–0.05, n = 34) | 0.02 (0.01–0.04, n = 61) | 0.503 | 0.02 (0.01–0.038, n = 14) | 0.490 |
| Mean platelet volume (9.3–12.1 fl) | 11.05 (9.99–11.48, n = 34) | 1.04 (10.45–11.0, n = 61) | 0.088 | 10.9 (10.5–11.4, n = 15) | 0.061 |
a
Comparison between SSTI and herpes zoster (HZ).
b
Comparison between herpes zoster and herpes zoster with secondary infection.